SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $57 | -58.1% | 498 | -49.8% | 0.00% | -100.0% |
| Q1 2023 | $136 | +18.3% | 992 | +11.2% | 0.00% | 0.0% |
| Q4 2022 | $115 | -100.0% | 892 | -83.1% | 0.00% | -66.7% |
| Q3 2022 | $581,000 | +159.4% | 5,276 | +75.6% | 0.00% | +200.0% |
| Q2 2022 | $224,000 | -56.1% | 3,005 | -47.1% | 0.00% | -50.0% |
| Q4 2021 | $510,000 | -17.3% | 5,683 | -15.0% | 0.00% | 0.0% |
| Q3 2021 | $617,000 | +116.5% | 6,684 | +75.0% | 0.00% | +100.0% |
| Q1 2021 | $285,000 | +917.9% | 3,819 | +2107.5% | 0.00% | – |
| Q2 2020 | $28,000 | – | 173 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |